Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

髓系抗原呈递细胞微环境维持抗肿瘤T细胞,并通过CD28共刺激促进PD-1阻断。

阅读:6
作者:Jaikumar Duraiswamy ,Riccardo Turrini ,Aspram Minasyan ,David Barras ,Isaac Crespo ,Alizée J Grimm ,Julia Casado ,Raphael Genolet ,Fabrizio Benedetti ,Alexandre Wicky ,Kalliopi Ioannidou ,Wilson Castro ,Christopher Neal ,Amandine Moriot ,Stéphanie Renaud-Tissot ,Victor Anstett ,Noémie Fahr ,Janos L Tanyi ,Monika A Eiva ,Connor A Jacobson ,Kathleen T Montone ,Marie Christine Wulff Westergaard ,Inge Marie Svane ,Lana E Kandalaft ,Mauro Delorenzi ,Peter K Sorger ,Anniina Färkkilä ,Olivier Michielin ,Vincent Zoete ,Santiago J Carmona ,Periklis G Foukas ,Daniel J Powell Jr ,Sylvie Rusakiewicz ,Marie-Agnès Doucey ,Denarda Dangaj Laniti ,George Coukos

Abstract

The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we show that tumor-specific CD8+ TIL accumulate in tumor islets, where they engage antigen and upregulate PD-1, which restrains their functions. Intraepithelial PD-1+CD8+ TIL can be, however, polyfunctional. PD-1+ TIL indeed exhibit a continuum of exhaustion states, with variable levels of CD28 costimulation, which is provided by antigen-presenting cells (APC) in intraepithelial tumor myeloid niches. CD28 costimulation is associated with improved effector fitness of exhausted CD8+ TIL and is required for their activation upon PD-1 blockade, which also requires tumor myeloid APC. Exhausted TIL lacking proper CD28 costimulation in situ fail to respond to PD-1 blockade, and their response may be rescued by local CTLA-4 blockade and tumor APC stimulation via CD40L.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。